BNTC R&D to Revenue
Benitec Biopharma Inc · R&D to Revenue
BNTC R&D to Revenue
Latest reported0.00%period ending
BNTC FY R&D/Revenue (1096.75% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
BNTC r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 17,032% | |
| 15,441.0959% | |
| 11,898.3051% | |
| 3,093.8144% | |
| 18.2974% | |
| 84.6609% | |
| 2,079.5816% | |
| 2,863.5881% | |
| 576.134% | |
| 576.1336% | |
| 628.4292% | |
| 404.5901% | |
| 817.04% | |
| 801.3631% | |
| 481.4822% | |
| 207.0525% | |
| 0% | |
| 93.0664% | |
| 574.0027% | |
| 1,096.7549% |